Target intelligence / Profile preview

Macrophage phagocytosis pathway

Molecular classification
Receptor (specifically Fcγ receptor and complement receptor families), Signaling pathway, Cytoskeletal remodeling machinery (actin, microtubule, myosin proteins), Enzyme (PI 3-kinase, PKC, PLCγ, ERK, Rho GTPases)
01

Overview

The macrophage phagocytosis pathway encompasses the molecular and cellular processes by which macrophages detect, engulf, and destroy pathogens, apoptotic cells, and cellular debris. This pathway is initiated by the binding of ligands (e.g., antibody-opsonized particles via Fcγ receptors or complement-opsonized particles via complement receptors) to specific receptors on the macrophage surface[1][3]. Receptor engagement triggers a cascade of intracellular signaling events, including the activation of kinases (Syk, PI 3-kinase, PKC, ERK), modulation of phosphoinositide lipids, and dynamic remodeling of the actin and microtubule cytoskeleton to form membrane protrusions that engulf the target[1][3]. The engulfed particle is enclosed within a phagosome, which matures through fusion with endosomes and lysosomes to become a phagolysosome, where the particle is degraded by acidic and enzymatic action[1]. The pathway is critical for innate immunity, inflammation resolution, tissue homeostasis, and wound healing, and its dysregulation is implicated in infections, chronic inflammatory diseases, atherosclerosis, and cancer[1][5]. Macrophage phagocytic capacity and receptor expression can change with differentiation state and environmental cues, highlighting the plasticity and context-dependence of this pathway[1].

Other names
Phagocytic pathway in macrophagesMacrophage phagocytic receptor signaling pathwayFcγ receptor-mediated phagocytosis pathwayComplement receptor-mediated phagocytosis pathway
02

Mechanism of action

Receptor engagement (Fcγ receptor or complement receptor) initiates intracellular signaling cascades. Phosphoinositide metabolism (PI 3-kinase, PLCγ) and lipid remodeling at the phagocytic cup. Cytoskeletal rearrangement (actin polymerization/depolymerization via Arp2/3 complex, Rho, Rac, Cdc42 GTPases). Phagosome formation and maturation via sequential fusion with endosomes and lysosomes. Acidification and enzymatic degradation within the phagolysosome.

03

Biological functions

Immune response (innate immunity)Pathogen clearanceCellular debris removalAntigen presentationInflammation resolutionTissue homeostasisWound healingLipid metabolism (in atherosclerosis)
04

Disease associations

Infection (bacterial, fungal, viral)Chronic inflammationAtherosclerosisAutoimmune diseaseCancer (tumor-associated macrophages)Chronic wound healing disorders
05

Safety considerations

Overactivation can lead to excessive inflammation and tissue damageImpaired phagocytosis (e.g., chronic wounds, atherosclerosis) results in failure to resolve inflammation or clear pathogens[5]Potential for immunosuppression if pathway is inhibitedRisk of autoimmunity or infection with therapeutic modulation
06

Interacting drugs

Immunomodulatory drugs (e.g., monoclonal antibodies targeting Fcγ receptors) can indirectly influence macrophage phagocytosis

1 more in the full profile.

07

Biomarkers

Surface markers: CD206 (MRC1), CD163, TIMD4, MERTK (associated with phagocytic activity in steady-state and inflammatory conditions)[6]Intracellular markers: Activation of Syk, PI 3-kinase, PKC, ERK, Rho GTPasesFunctional assays: Phagocytic index, bacterial killing assays

Beyond the preview

Go deeper on Macrophage phagocytosis pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Macrophage phagocytosis pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call